After assisting with an MDI for an acute asthma attack, what is the next step?

After assisting with an MDI for an acute asthma attack, what is the next step?

• A. Administer a second dose of MDI
• B. Have the patient rest without reassessment
• C. Reassess the patient and document her response
• D. Remove the inhaler and move to transport

Answer: (C)

After giving a bronchodilator with a metered-dose inhaler, the immediate step is to reassess the patient and document how she responds. This check is essential because it shows whether the treatment helped, hadn’t effect, or, in some cases, made things worse, and it directly informs what you do next. Reassessment involves noting breathing effort and work of breathing, lung sounds, oxygen saturation if available, heart rate, color, and the patient’s ability to speak in full sentences. If there’s clear improvement, you can continue monitoring and proceed with transport. If there’s little or no improvement, the reassessment guides whether another dose is indicated or if escalation of care is needed. Documentation should record the time, dose given, observed response, any side effects, and the plan for ongoing care and transport. Resting without reassessment runs the risk of missing changes in condition. A second dose is considered based on reassessment results, not automatic. Removing the inhaler and moving to transport isn't the next step without confirming how the patient has responded to the initial treatment.

After giving a bronchodilator with a metered-dose inhaler, the immediate step is to reassess the patient and document how she responds. This check is essential because it shows whether the treatment helped, hadn’t effect, or, in some cases, made things worse, and it directly informs what you do next.

Reassessment involves noting breathing effort and work of breathing, lung sounds, oxygen saturation if available, heart rate, color, and the patient’s ability to speak in full sentences. If there’s clear improvement, you can continue monitoring and proceed with transport. If there’s little or no improvement, the reassessment guides whether another dose is indicated or if escalation of care is needed. Documentation should record the time, dose given, observed response, any side effects, and the plan for ongoing care and transport.

Resting without reassessment runs the risk of missing changes in condition. A second dose is considered based on reassessment results, not automatic. Removing the inhaler and moving to transport isn't the next step without confirming how the patient has responded to the initial treatment.